Published in J Clin Oncol on July 19, 2010
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res (2011) 2.86
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov (2012) 2.51
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density. J Natl Cancer Inst (2013) 2.21
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst (2012) 1.80
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Benign breast disease, mammographic breast density, and the risk of breast cancer. J Natl Cancer Inst (2013) 1.34
Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol (2011) 1.23
Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res (2013) 1.23
Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study. Breast Cancer Res (2012) 1.16
The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst (2015) 1.11
Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat (2011) 1.05
Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. Radiology (2014) 0.98
Mammographic density and breast cancer risk in White and African American Women. Breast Cancer Res Treat (2012) 0.96
Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer. Clin Cancer Res (2013) 0.95
Density is in the eye of the beholder: visual versus semi-automated assessment of breast density on standard mammograms. Insights Imaging (2011) 0.93
High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res (2015) 0.93
Awareness of breast density and its impact on breast cancer detection and risk. J Clin Oncol (2015) 0.93
Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat (2012) 0.92
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to the time since the mammogram. Cancer Epidemiol Biomarkers Prev (2013) 0.91
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk. J Mammary Gland Biol Neoplasia (2013) 0.90
AutoDensity: an automated method to measure mammographic breast density that predicts breast cancer risk and screening outcomes. Breast Cancer Res (2013) 0.90
Mammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer. Cancer Causes Control (2012) 0.89
Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. Acad Radiol (2013) 0.88
Vitamin D and mammographic breast density: a systematic review. Cancer Causes Control (2011) 0.86
Physical activity and mammographic breast density: a systematic review. Breast Cancer Res Treat (2012) 0.86
Relationship between breast cancer risk factors and mammographic breast density in the Fernald Community Cohort. Br J Cancer (2012) 0.86
Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals. Br J Cancer (2011) 0.85
Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics. Cancer Epidemiol Biomarkers Prev (2015) 0.85
Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer (2015) 0.82
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors. Breast Cancer Res Treat (2015) 0.81
Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat (2011) 0.80
Postmenopausal hormone therapy and breast cancer risk: current status and unanswered questions. Endocrinol Metab Clin North Am (2011) 0.80
Breast density influences tumor subtypes and tumor aggressiveness. J Natl Cancer Inst (2011) 0.79
Using multiscale texture and density features for near-term breast cancer risk analysis. Med Phys (2015) 0.79
Do fatty breasts increase or decrease breast cancer risk? Breast Cancer Res (2012) 0.78
Skeletal manifestations of treatment of breast cancer. Curr Osteoporos Rep (2013) 0.77
Reduced expression levels of let-7c in human breast cancer patients. Oncol Lett (2015) 0.77
Effect of preventive hormonal therapy on breast density: a systematic qualitative review. ScientificWorldJournal (2014) 0.77
Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer. BMC Cancer (2015) 0.77
Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination. Int J Womens Health (2013) 0.76
Improved digital breast tomosynthesis images using automated ultrasound. Med Phys (2014) 0.76
Breast Imaging Reporting and Data System (BI-RADS) breast composition descriptors: automated measurement development for full field digital mammography. Med Phys (2013) 0.76
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BMC Cancer (2017) 0.75
Women with abnormal screening mammography lost to follow-up: An experience from Taiwan. Medicine (Baltimore) (2016) 0.75
Investigation of mammographic breast density as a risk factor for ovarian cancer. J Natl Cancer Inst (2013) 0.75
Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis. Breast Cancer Res (2016) 0.75
MRI screening for breast cancer in women at high risk; is the Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer? J Med Radiat Sci (2015) 0.75
Association between air pollution and mammographic breast density in the Breast Cancer Surveilance Consortium. Breast Cancer Res (2017) 0.75
Using DRS during breast conserving surgery: identifying robust optical parameters and influence of inter-patient variation. Biomed Opt Express (2016) 0.75
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 10.35
Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol (1997) 7.62
Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst (2002) 6.28
Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19
Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst (1995) 5.93
Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst (1995) 5.35
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med (2008) 4.81
Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst (2003) 3.83
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA (2006) 3.29
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst (2004) 2.87
Association between mammography timing and measures of screening performance in the United States. Radiology (2005) 2.85
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 2.71
Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA (2001) 2.45
Categorizing breast mammographic density: intra- and interobserver reproducibility of BI-RADS density categories. Breast (2005) 2.06
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Partly conditional survival models for longitudinal data. Biometrics (2005) 1.94
Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.91
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Influence of age and parity on the development of the human breast. Breast Cancer Res Treat (1992) 1.54
Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors. Radiology (2004) 1.51
A prospective study of breast cancer risk using routine mammographic breast density measurements. Cancer Epidemiol Biomarkers Prev (2004) 1.43
Reproductive and hormonal factors associated with mammographic breast density by age (United States). Cancer Causes Control (2000) 1.36
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol (2009) 1.35
Influence of mammographic parenchymal pattern in screening-detected and interval invasive breast cancers on pathologic features, mammographic features, and patient survival. AJR Am J Roentgenol (2007) 1.34
Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev (2002) 1.28
Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2008) 1.19
Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol (2000) 1.16
Postmenopausal hormone therapy and changes in mammographic density. J Clin Oncol (2007) 1.01
Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med (2014) 11.30
Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med (2009) 10.27
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med (2003) 7.73
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04
Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst (2006) 5.17
Comparing yoga, exercise, and a self-care book for chronic low back pain: a randomized, controlled trial. Ann Intern Med (2005) 5.11
Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst (2007) 5.08
Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA (2012) 4.71
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
Comparison of screening mammography in the United States and the United kingdom. JAMA (2003) 4.53
Performance benchmarks for screening mammography. Radiology (2006) 4.41
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med (2011) 4.31
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Does utilization of screening mammography explain racial and ethnic differences in breast cancer? Ann Intern Med (2006) 3.95
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Performance of first mammography examination in women younger than 40 years. J Natl Cancer Inst (2010) 3.53
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Breast cancer treatment of older women in integrated health care settings. J Clin Oncol (2006) 3.46
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol (2007) 3.42
Performance benchmarks for diagnostic mammography. Radiology (2005) 3.40
Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol (2007) 3.06
Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology (2009) 2.88
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med (2012) 2.85
When radiologists perform best: the learning curve in screening mammogram interpretation. Radiology (2009) 2.78
Longitudinal measurement of clinical mammographic breast density to improve estimation of breast cancer risk. J Natl Cancer Inst (2007) 2.75
Physician predictors of mammographic accuracy. J Natl Cancer Inst (2005) 2.72
Screening mammograms by community radiologists: variability in false-positive rates. J Natl Cancer Inst (2002) 2.71
Do we need to adjudicate major clinical events? Clin Trials (2008) 2.61
Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women. Am J Clin Nutr (2006) 2.52
Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain (2005) 2.50
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg (2007) 2.43
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst (2009) 2.35
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol (2009) 2.33
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
A randomized trial comparing yoga, stretching, and a self-care book for chronic low back pain. Arch Intern Med (2011) 2.27
Are breast density and bone mineral density independent risk factors for breast cancer? J Natl Cancer Inst (2005) 2.21
Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med (2003) 2.19
Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med (2013) 2.15
Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med (2007) 2.10
Using natural language processing to improve efficiency of manual chart abstraction in research: the case of breast cancer recurrence. Am J Epidemiol (2014) 2.09
Identifying minimally acceptable interpretive performance criteria for screening mammography. Radiology (2010) 2.06
Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population. J Clin Oncol (2003) 2.02
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst (2007) 1.95
Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer (2007) 1.94
Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography. Cancer (2006) 1.92
Association between telomere length, specific causes of death, and years of healthy life in health, aging, and body composition, a population-based cohort study. J Gerontol A Biol Sci Med Sci (2009) 1.90
The random dialing survey as a tool for community consultation for research involving the emergency medicine exception from informed consent. Ann Emerg Med (2008) 1.88
Modelling the cumulative risk of a false-positive screening test. Stat Methods Med Res (2010) 1.87
Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev (2004) 1.82
Gene expression profiles reveal increased mClca3 (Gob5) expression and mucin production in a murine model of asbestos-induced fibrogenesis. Am J Pathol (2005) 1.82
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Influence of annual interpretive volume on screening mammography performance in the United States. Radiology (2011) 1.81
Breast cancer incidence in the randomized PEARL trial of lasofoxifene in postmenopausal osteoporotic women. J Natl Cancer Inst (2010) 1.79
Novel use of single X-ray absorptiometry for measuring breast density. Technol Cancer Res Treat (2005) 1.78
Predicting survival after out-of-hospital cardiac arrest: role of the Utstein data elements. Ann Emerg Med (2009) 1.77
Biennial versus annual mammography and the risk of late-stage breast cancer. J Natl Cancer Inst (2004) 1.76
Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol (2002) 1.75
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev (2009) 1.75
NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73
Breast cancer detection rate: designing imaging trials to demonstrate improvements. Radiology (2007) 1.73
Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer (2007) 1.71
Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst (2012) 1.70
Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev (2005) 1.69
Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med (2007) 1.65
Hypertonic resuscitation: design and implementation of a prehospital intervention trial. J Am Coll Surg (2007) 1.61
A comparison of the effects of 2 types of massage and usual care on chronic low back pain: a randomized, controlled trial. Ann Intern Med (2011) 1.58
A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res (2014) 1.56
Airway epithelial NF-kappaB activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol (2007) 1.53
Physician workload in mammography. AJR Am J Roentgenol (2008) 1.53
Self-detection remains a key method of breast cancer detection for U.S. women. J Womens Health (Larchmt) (2011) 1.53
A neighborhood wealth metric for use in health studies. Am J Prev Med (2011) 1.53
Comparing the performance of mammography screening in the USA and the UK. J Med Screen (2005) 1.52
A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring. Biometrics (2013) 1.52
Modeling the dissemination of mammography in the United States. Cancer Causes Control (2005) 1.52
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Res (2010) 1.51
Short-term (1-2 mo) hormone therapy cessation before mammography. Menopause (2009) 1.50
Recommendation for short-interval follow-up examinations after a probably benign assessment: is clinical practice consistent with BI-RADS guidance? AJR Am J Roentgenol (2010) 1.49
A trial of an activating intervention for chronic back pain in primary care and physical therapy settings. Pain (2005) 1.49
Child obesity associated with social disadvantage of children's neighborhoods. Soc Sci Med (2010) 1.48
Risk factors for inflammatory breast cancer and other invasive breast cancers. J Natl Cancer Inst (2013) 1.48
Statin use and prostate cancer risk in a large population-based setting. Cancer Causes Control (2008) 1.47